The shortcomings of healthcare services in the rural Eastern Cape is well documented. Now, with provinces gearing up for the COVID-19 vaccine rollout, Luvuyo Mehlwana asked local health activists and government leaders about the rollout plan for rural communities in the province.
Government deserves criticism for various aspects of its COVID-19 response, but some social media criticism following Sunday’s announcement that the Oxford University/AstraZeneca vaccine has little or no efficacy in preventing mild-to-moderate disease caused by the 501Y.V2 variant has been unfair, writes Marcus Low.
While local experts generally welcome the order in which vaccines will be provided to different categories of people in South Africa, they are concerned that some practical nuances are unclear. Elna Schütz reports.
Local researchers have welcomed impressive phase III findings for the Russian-made Sputnik V vaccine published this week in the Lancet medical journal. It is the sixth COVID-19 vaccine found to be effective in preliminary data from a phase III randomised controlled trial and the fourth to have phase III findings published in a leading medical journal.
In allowing section 21 applications as part of a controlled compassionate access programme, SAHPRA has essentially shifted the responsibility for deciding whether the anti-parasitic ivermectin is safe and effective enough to be used in the treatment of COVID-19 to doctors. This places an enormous responsibility on doctors, writes Adele Baleta.
From paintings by artists like Xolani Sivunda to communication campaigns launched by provincial health departments, the fight against COVID-19-related misinformation is being fought on many fronts. Siyabonga Kamnqa surveyed some of these efforts and asked health and behaviour experts what does and does not work.
South Africa has struggled to secure adequate stock of urgently needed COVID-19 vaccines. This has raised questions about the state of the country’s local vaccine manufacturing capacity and why, after almost two decades of government support, South Africa’s partially state-owned vaccine manufacturer Biovac is not better positioned to respond to the pandemic. Catherine Tomlinson investigates.